A61M27/008

Nephrostomy tube
11446476 · 2022-09-20 ·

The present disclosure discloses a nephrostomy tube and a nephrostomy tube with curved drainage. The nephrostomy tube with curved drainage includes a bending head, a balloon element, and an elongated main body integrally connected with each other, wherein the nephrostomy tube with curved drainage has an guiding channel adapted for a guiding member to penetrate through, wherein the bending head has a first inner channel and at least two drainage bending channels located on the outer side of the first inner channel, wherein the balloon element has an air chamber and a second inner channel, wherein the at least two drainage bending channels are communicated with the second inner channel, wherein the elongated main body has a third inner channel communicated with the second inner channel of the balloon element, wherein the first inner channel, the second inner channel and the third inner channel from the guiding channel.

Systems, devices and methods for draining and analyzing bodily fluids

Systems, devices and methods for draining and analyzing bodily fluids are disclosed in which a drainage assembly is configured to prevent negative pressure build-up. The drainage assembly generally includes a catheter which may include a drainage lumen, a reservoir, a venting mechanism in fluid communication with the drainage lumen and a positive pressure lumen, and a controller. The venting mechanism may further include a valve which is configured to maintain a closed position, as well as a vent in fluid communication with the valve, where the venting mechanism is configured to inhibit wetting of the vent from fluid within the drainage lumen.

Ureteral stent for placement in a kidney and bladder

Provided is a ureteral stent including a bladder portion positioned in a bladder of a patient, a kidney portion positioned in a kidney and ureteral passageway of the patient, and one or more tethers coupling the bladder portion to the kidney portion. The ureteral stent allows urine to pass around a blockage, and allows a ureter orifice connecting the ureteral passageway to the bladder to move between a compressed state and an uncompressed state to prevent or minimize urinary reflux, flank pain, blood in the urine, etc., while allowing the bladder portion to move freely in the bladder to prevent the bladder portion from irritating the trigone muscle.

CONTROLLED EXTENSION STENT

The present disclosure relates generally to controlled extension medical stents, and more particularly to controlled extension devices positioned in the body to stent the ureter and facilitate drainage from the kidney to the bladder.

Closed system with intermittent urinary catheter feed
11285292 · 2022-03-29 · ·

A sterile closed intermittent urinary catheter system which is an easier to use by virtue of ergonomic shaping to facilitate advancement and retrieval of the catheter from the collection bag. The bag may have a closed internal hole adjacent an indent in one edge that creates a narrow channel through which the catheter passes. The narrow channel is located near to and in alignment with an outlet assembly so that the catheter extends from the narrow channel directly to the outlet. A user may easily grasp the catheter from outside the bag at the narrow channel and urge the catheter forward or backward to alternately extend and retract it through the outlet. A flexible pusher sleeve with gripper features may be added around the narrow channel to further facilitate catheter advancement.

IINCREASED DRAINAGE AND DECREASED INTERNAL STRESS URETERAL STENT DESIGN

A ureteral stent may comprise an elongate member with an internal-luminal space. The member may have at least one end coiled in a pigtail-shape, a substantially straight portion, and a plurality of side ports wherein the plurality of side ports are located only in the substantially straight portion and are disposed along a spiral or helix where each side port is located radially and longitudinally offset relative to each adjacent side port.

EXTENDED RELEASE DEVICES AND THERAPEUTICS FOR LONG TERM TREATMENT OF URINARY TRACT INFECTION IN-VIVO
20220105326 · 2022-04-07 ·

Devices and extended release therapeutics for the in-vivo long term treatments urinary tract infection.

SYSTEMS, DEVICES, AND METHODS FOR THE RETRIEVAL OF AN IMPLANT IN THE PROSTATIC URETHRA
20220110737 · 2022-04-14 ·

Systems, devices, and methods are provided for retrieval of an implant from the prostatic urethra. Embodiments of retrieval systems can include a device for insertion into the patient and a proximal control device for use in grasping a portion of the implant and withdrawing the implant into a lumen of the retrieval system.

Systems and Methods to Facilitate the Non-Surgical Management of Obstructive Urolithiasis
20220072213 · 2022-03-10 · ·

The present invention discloses systems and methods for use in the treatment and management of obstructive urolithiasis. A coupling device between a nephrostomy tube and external fluid and control connections may be used in some embodiments of the present invention. This coupling device may provide a quick connection between the nephrostomy tube and a reservoir for irrigation and a collection container for drainage of the kidney. In some embodiments, a triple lumen nephrostomy tube may be used to house an irrigation catheter for irrigation of the patient's kidneys and a ureteral modulation wire and enable drainage of fluid from the kidneys. The ureteral modulation wire may be inserted into the patient's ureter through the kidney in conjunction with the nephrostomy tube. A harness system is also disclosed that may be used in conjunction with the coupling device and the triple lumen nephrostomy tube to enable a patient to independently control irrigation and drainage of the kidney.

Compositions, Dispensers, and Methods Thereof for Establishing a Urine Passageway Through a Ureter
20220062609 · 2022-03-03 ·

Disclosed are compositions, dispensers, and methods thereof for establishing a urine passageway through a ureter. For example, a composition can include, in some embodiments, a primary solid phase and a secondary solid phase. The primary solid phase can include a monomer, a pre-polymer, or a mixture thereof configured to commence polymerization into a polymeric form in the ureter when contacted with a fluid such as urine or saline. The secondary solid phase is dispersed in the primary solid phase. The secondary solid phase can include a leachable component. The leachable component is configured to leach from the polymeric form when contacted with a sufficient amount of a same or different fluid. The leachable component is also configured to form pores of an open-pore network throughout the polymeric form when leached from the polymeric form, thereby establishing the urine passageway through the ureter.